stoxline Quote Chart Rank Option Currency Glossary
  
T2 Biosystems, Inc. (TTOO)
2.94  -0.1 (-3.29%)    04-17 16:00
Open: 3.07
High: 3.0787
Volume: 62,750
  
Pre. Close: 3.04
Low: 2.88
Market Cap: 16(M)
Technical analysis
2024-04-17 4:50:08 PM
Short term     
Mid term     
Targets 6-month :  4.82 1-year :  5.85
Resists First :  4.12 Second :  5.01
Pivot price 2.98
Supports First :  2.7 Second :  2.24
MAs MA(5) :  3.04 MA(20) :  2.97
MA(100) :  4.35 MA(250) :  13.51
MACD MACD :  -0.4 Signal :  -0.4
%K %D K(14,3) :  38.1 D(3) :  48.1
RSI RSI(14): 37.1
52-week High :  70 Low :  2.7
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ TTOO ] has closed above bottom band by 40.9%. Bollinger Bands are 78.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 3.08 - 3.1 3.1 - 3.11
Low: 2.84 - 2.86 2.86 - 2.87
Close: 2.91 - 2.94 2.94 - 2.96
Company Description

T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida, a direct-from-blood test that identifies blood stream infections that causes sepsis and candidemia; T2Bacteria, a direct-from-blood test, which detects bacterial pathogens associated with sepsis; T2Resistance to identify carbapenem resistance genes; and T2SARS-CoV-2 panel to detect SARS-CoV-2 virus. In addition, it is developing T2Biothreat for detection of biothreat pathogens; comprehensive sepsis panel to detect bloodstream infections caused by bacterial and Candida species, and antibiotic resistant markers; T2Cauris to provide direct detection of the emerging superbug Candida auris in patient skin, patient blood, and hospital environmental samples; and T2Lyme, a direct-from-blood test panel designed to run on the T2Dx Instrument to identify the bacteria that cause Lyme disease. The company has collaboration agreements with Canon U.S. Life Sciences, Inc. to develop a diagnostic test panel to detect Lyme disease. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

Headline News

Thu, 11 Apr 2024
T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity - GlobeNewswire

Thu, 28 Mar 2024
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc. - GlobeNewswire

Thu, 28 Mar 2024
Is T2 Biosystems Inc (TTOO) a Winner in the Diagnostics & Research Industry? - InvestorsObserver

Tue, 26 Mar 2024
T2 Biosystems Inc (TTOO) Stock Is Down -15.76% This Week: Buy, Hold, or Sell? - InvestorsObserver

Thu, 15 Feb 2024
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results - Yahoo Finance

Wed, 07 Feb 2024
T2 Biosystems to Report Fourth Quarter and Full Year 2023 Financial Results and Business Updates on February 15 ... - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Diagnostics & Research
Shares Out 6 (M)
Shares Float 5 (M)
Held by Insiders 6.7 (%)
Held by Institutions 19.2 (%)
Shares Short 397 (K)
Shares Short P.Month 316 (K)
Stock Financials
EPS -19.2
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -6.91
Profit Margin 0 %
Operating Margin -555.1 %
Return on Assets (ttm) -85.3 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth -69.5 %
Gross Profit (p.s.) 0
Sales Per Share 1.3
EBITDA (p.s.) -8.41
Qtrly Earnings Growth 0 %
Operating Cash Flow -48 (M)
Levered Free Cash Flow -23 (M)
Stock Valuations
PE Ratio -0.16
PEG Ratio 0
Price to Book value -0.43
Price to Sales 2.25
Price to Cash Flow -0.34
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android